London,U.K (PRWEB) July 23, 2004 -- Berkshire Holding Corporation, the UK arm of Berkshire Biotechnology Holding Corporation., a private Texas corporation, has acquired one hundred percent of the issued and outstanding shares of IPO Holding Company Inc., (Nevada) in a negotiated private transaction.
In the acquisition, IPO Holding Company selling shareholders received a combination of cash and common shares of Berkshire Biotechnology Holding Corporation. The assets of IPO Holding Company include 20,000,000 shares of International Pharmaceutical Outlets Inc., preferred stock (IPCY-Pink Sheets). International Pharmaceutical Outlets Inc is in the process of corporate reorganization.
Berkshire Biotechnology Holdings Corporation is a Business Development Company under the Investment Act of 1940. Berkshire operates as an institutional investor and operator of investments in specific emerging market sectors.
Source; Berkshire Biotechnology Holdings Corporation
www.berkshireBDC.com
info@BerkshireBDC.com
Berkshire Biotechnology Holdings Corporation is a Business Development Company, operated pursuant to the Investment Companies Act of 1940. It holds various enterprises as investments and seeks to grow companies in which it has an interest.
Safe Harbor Statement.
Under the Private Securities Litigation Reform Act of 1995:
The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, regulatory approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties as may be detailed in the Company's filings with the Securities and Exchange Commission.
# # #
|
